Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force.
暂无分享,去创建一个
G. Guyatt | G. Raskob | H. Schünemann | E. Hylek | D. Addrizzo-Harris | D. Gutterman | M. Baumann | B. Phillips | S. Lewis
[1] Douglas K Owens,et al. Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force. , 2006, Chest.
[2] S. Pauker,et al. Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.
[3] G. Lip,et al. Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.
[4] Clifford W Colwell,et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.
[5] Giancarlo Agnelli,et al. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.
[6] A. Greinacher,et al. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.
[7] G. Guyatt,et al. Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.
[8] Mohit Bhandari,et al. Patients at the centre: in our practice, and in our use of language , 2004, ACP journal club.
[9] D. Goldfarb. Patients at the centre: in our practice, and in our use of language , 2004, ACP journal club.
[10] R. Thomson,et al. Decision aids for people facing health treatment or screening decisions. , 2003, The Cochrane database of systematic reviews.
[11] G. Guyatt,et al. A systematic review and meta-analysis of studies comparing mortality rates of private for-profit and private not-for-profit hospitals. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[12] P. Jones,et al. Corticosteroid therapy in pulmonary sarcoidosis: a systematic review. , 2002, JAMA.
[13] J. Cox,et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. , 2001, BMJ : British Medical Journal.
[14] B. Chong,et al. Prospective Randomised Open-label Comparison of Danaparoid with Dextran 70 in the Treatment of Heparin-induced Thrombocytopaenia with Thrombosis , 2001, Thrombosis and Haemostasis.
[15] J. Heit,et al. Prevention of venous thromboembolism. , 2001, Clinics in geriatric medicine.
[16] H. Büller,et al. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. , 1999, Stroke.
[17] G. Guyatt,et al. Economic analysis of respiratory rehabilitation. , 1997, Chest.
[18] David Schultz,et al. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996, The Lancet.
[19] Salim Yusuf,et al. Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials , 1996, BMJ.
[20] D. Clement. A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .
[21] F Clerc,et al. Long-term results of valve replacement with the St. Jude Medical prosthesis. , 1995, The Journal of thoracic and cardiovascular surgery.
[22] G. Clagett,et al. Antithrombotic therapy in peripheral arterial occlusive disease. , 1992, Chest.
[23] R. Hull,et al. Antithrombotic therapy for venous thromboembolic disease. , 1986, Chest.